Page last updated: 2024-12-07

deriphyllin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID122562
SCHEMBL ID8494464
MeSH IDM0076897

Synonyms (12)

Synonym
32156-80-2
deriphyllin
hydroxyethyltheophylline complet
theophylline diethanolamine
x3d62bxx1r ,
unii-x3d62bxx1r
theophylline diethanolamine [mi]
SCHEMBL8494464
1,3-dimethyl-7h-purine-2,6-dione;2-(2-hydroxyethylamino)ethanol
Q27293506
1,3-dimethyl-3,9-dihydro-1h-purine-2,6-dione--2,2'-azanediyldi(ethan-1-ol) (1/1)
DTXSID90954028

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"In rabbits, a three way cross-over test was carried out to assess bioavailability of digoxin from commercially available 'Deriphyllin-Digoxin' tablets."( Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
Bansinath, M; Chopra, KS; Ghosh, SS; Mathur, VS; Shukla, VK, 1986
)
0.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 103.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index103.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index181.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (103.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (20.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]